Tag: DGX

  • Medical Laboratories & Research: Organovo Holdings (NYSEMKT:ONVO), Thermo Fisher Scientific (NYSE:TMO), Agilent Technologies (NYSE:A), Quest Diagnostics (NYSE:DGX)

    Organovo Holdings, Inc. (NYSE MKT:ONVO) , a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, announced that it has been invited to participate at the Citi 2014 Global Healthcare Conference, which will be held in New York February 24 – 26, 2014. Organovo Holdings Inc (NYSEMKT:ONVO) stock opened at $10.38 in last session, and closed at $10.50, while the day range of ONVO stock is $10.20 – $10.84. The stock showed a positive weekly performance of 5.85%.

    Fair trade watchdog CCI has approved General Electric Company’s proposed acquisition of businesses of Thermo Fisher Scientific Inc. (NYSE:TMO), saying the deal will not have an adverse impact on competition in India. Thermo Fisher Scientific Inc. (NYSE:TMO) stock opened at $124.71, in last session and closed at $123.18, by losing -1.23%. The 52 week range of TMO is $71.60 – $125.01. Company’s market capitalization is $44.51billion.

    Agilent Technologies Inc (NYSE:A) of Santa Clara, CA, USA has launched the ADS 2014 version of the Agilent EEsof EDA Advanced Design System electronic design automation software for RF, microwave and signal-integrity applications. Agilent Technologies Inc. (NYSE:A) stock decreased -1.66% and finished the last session at $56.34. The EPS of the stock remained 2.17. Company’s market capitalization is $18.82billion.

    Quest Diagnostics Inc (NYSE:DGX) was upgraded by analysts at Jefferson Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. Quest Diagnostics Inc (NYSE:DGX) stock opened the session at $52.97, and closed the session at $53.05. The 52 week range of the DGX stock remained $50.46 – $64.10 and the day range was $52.80 – $53.09.